MS
Myneni Srikanth
About Myneni Srikanth
Myneni Srikanth has 17 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Srishti Udyog Llp and Pulse Pharmaceuticals Private Limited. Formerly with 2 companies, such as Srishti Udyog Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Srishti Udyog Llp
AAZ-2491
|
Designated Partner | 28 Oct 2021 | 2021 | Active |
Pulse Pharmaceuticals Private Limited
U24239TG1997PTC026151
|
Director | 01 Sep 2017 | 1997 | Active |
Vizag International Private Limited
U74120AP2012PTC080811
|
Director | 19 Feb 2024 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Srishti Udyog Private Limited
U45200AP2008PTC057282
|
Director | 01 May 2009 | 2008 | Converted To Llp |
Nexera Pharma Private Limited
U24290TG2017PTC116519
|
Director | 13 Apr 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Myneni Srikanth
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myneni Srikanth
Myneni Srikanth has 17 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Srishti Udyog Llp and Pulse Pharmaceuticals Private Limited. Formerly with 2 companies, such as Srishti Udyog Private Limited. Engaged in General Business. Contributes to corporate operations.
Myneni Srikanth is associated with 3 companies as Designated Partner and Director.
Myneni Srikanth has expertise in General Business.
Myneni Srikanth has 17 years in corporate governance.